跳至主要内容
临床试验/NCT01611441
NCT01611441已完成不适用

Investigation of Biomarkers in an Exploratory Study in Patients With Osteoarthritis of the Knee Undergoing Total Knee Replacement Surgery

AstraZeneca2 个研究点 分布在 2 个国家目标入组 125 人开始时间: 2011年12月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
AstraZeneca
入组人数
125
试验地点
2
主要终点
Proportion of patients with upregulation of IL-6 or the IL-6 signalling pathway in the knee.

研究概览

简要总结

The main purpose of the study is to better understand how specific proteins/markers in blood, urine, synovial fluid (a lubricating fluid secreted by the membrane lining the joints), and joint tissue are involved in osteoarthritis of the knee. The aim is to investigate if there is a correlation between x-ray results, specific proteins/markers and different types of pain in patients with osteoarthritis of the knee. The study consists of 3 visits over 3-20 days and the last visit will be the day of surgery.

详细描述

Investigation of Biomarkers in an Exploratory Study in Patients with Osteoarthritis of the Knee Undergoing Total Knee Replacement Surgery

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
40 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients who will undergo a total knee replacement due to osteoarthritis.
  • Symptoms of the knee for at least 6 months prior to study start.

排除标准

  • Key-hole surgery performed on target knee within 3 months prior to study start.
  • History of disorders in which part of the immune system is missing or defective.

结局指标

主要结局

Proportion of patients with upregulation of IL-6 or the IL-6 signalling pathway in the knee.

时间窗: 3-20 days prior to day 1 (surgery) and day 1 (surgery) .

次要结局

  • Biomarkers by Magnetic Resonance Imaging (MRI).(1-5 days prior to day 1 (surgery).)
  • Polymorphisms in 10 specific genes.(3-20 days prior to day 1 (surgery) or at any time in the study.)
  • Biomarkers in synovial fluid, synovial membrane, and cartilage.(Day 1 (surgery).)
  • Biomarkers in blood and urine.(3-20 days prior to day 1 (surgery) and day 1 (surgery).)
  • WOMAC (Western Ontario and McMaster Osteoarthritis Index) variables and NPQ (Neuropathic Pain Questionnaire) variables.(3-20 days prior to day 1 (surgery) and 1-5 days prior to day 1 (surgery).)

研究者

发起方
AstraZeneca
申办方类型
Industry
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验